11. Editorial: diabetes and its association with hepatocellular carcinoma in chronic hepatitis B. Issue 1 (July 2015) Authors: Konerman, M.; Loomba, R. Journal: Alimentary pharmacology & therapeutics Issue: Volume 42:Issue 1(2015) Page Start: 117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Editorial: first‐degree relatives of Mexican Americans with HCC are at increased risk of significant fibrosis—authors' reply. Issue 9 (13th April 2023) Authors: Sharpton, S. R.; Loomba, R. Journal: Alimentary pharmacology & therapeutics Issue: Volume 57:Issue 9(2023) Page Start: 1038 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Editorial: further evidence for the use of advanced magnetic resonance imaging techniques to monitor NAFLD – authors' reply. Issue 9 (3rd April 2017) Authors: Lin, S. C.; Loomba, R. Journal: Alimentary pharmacology & therapeutics Issue: Volume 45:Issue 9(2017) Page Start: 1271 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Editorial: further evidence for the use of advanced magnetic resonance imaging techniques to monitor NAFLD – authors' reply. Issue 9 (May 2017) Authors: Lin, S. C.; Loomba, R. Journal: Alimentary pharmacology & therapeutics Issue: Volume 45:Issue 9(2017) Page Start: 1271 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Editorial: NAFLD in HIV infection – call for action. Authors' reply. Issue 6 (March 2015) Authors: Vodkin, I.; Loomba, R. Journal: Alimentary pharmacology & therapeutics Issue: Volume 41:Issue 6(2015) Page Start: 591 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Editorial: non‐alcoholic fatty liver disease―a pandemic in need of novel treatments and endpoints. Issue 1 (7th June 2017) Authors: Ajmera, V.; Loomba, R. Journal: Alimentary pharmacology & therapeutics Issue: Volume 46:Issue 1(2017) Page Start: 65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Editorial: non‐alcoholic fatty liver disease―a pandemic in need of novel treatments and endpoints. Issue 1 (July 2017) Authors: Ajmera, V.; Loomba, R. Journal: Alimentary pharmacology & therapeutics Issue: Volume 46:Issue 1(2017) Page Start: 65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Editorial: non‐invasive assessment of hepatic fibrosis in alpha‐1 antitrypsin deficiency using magnetic resonance elastography – authors' reply. Issue 6 (September 2016) Authors: Kim, R. G.; Loomba, R. Journal: Alimentary pharmacology & therapeutics Issue: Volume 44:Issue 6(2016) Page Start: 645 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Editorial: novel association between serum Pentraxin‐2 levels and advanced fibrosis in well‐characterised patients with non‐alcoholic fatty liver disease – authors' reply. Issue 6 (September 2015) Authors: Verna, E. C.; Loomba, R. Journal: Alimentary pharmacology & therapeutics Issue: Volume 42:Issue 6(2015) Page Start: 774 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. Editorial: obesity in chronic liver diseases – increased infections. Issue 2 (14th December 2015) Authors: Singh, S.; Loomba, R. Journal: Alimentary pharmacology & therapeutics Issue: Volume 43:Issue 2(2016) Page Start: 311 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗